Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Christian Julian Villabona-Arenas"'
Autor:
Luc Blassel, Anna Tostevin, Christian Julian Villabona-Arenas, Martine Peeters, Stéphane Hué, Olivier Gascuel, UK HIV Drug Resistance Database
Publikováno v:
PLoS Computational Biology, Vol 17, Iss 8, p e1008873 (2021)
Drug resistance mutations (DRMs) appear in HIV under treatment pressure. DRMs are commonly transmitted to naive patients. The standard approach to reveal new DRMs is to test for significant frequency differences of mutations between treated and naive
Externí odkaz:
https://doaj.org/article/f24dab1ce4724b9696dc6e25ea878cb0
Autor:
Raisa Raulino, Guillaume Thaurignac, Christelle Butel, Christian Julian Villabona-Arenas, Thomas Foe, Severin Loul, Simon-Pierre Ndimbo-Kumugo, Placide Mbala-Kingebeni, Sheila Makiala-Mandanda, Steve Ahuka-Mundeke, Karen Kerkhof, Eric Delaporte, Kevin K Ariën, Vincent Foulongne, Eitel Mpoudi Ngole, Martine Peeters, Ahidjo Ayouba
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 1, p e0009028 (2021)
BackgroundEpidemic arbovirus transmission occurs among humans by mosquito bites and the sylvatic transmission cycles involving non-human primates (NHPs) still exists. However, limited data are available on the extent in NHPs infections and their role
Externí odkaz:
https://doaj.org/article/0f95330dd51747289b9b328e04989d9c
Autor:
José Lourenço, Maricelia Maia de Lima, Nuno Rodrigues Faria, Andrew Walker, Moritz UG Kraemer, Christian Julian Villabona-Arenas, Ben Lambert, Erenilde Marques de Cerqueira, Oliver G Pybus, Luiz CJ Alcantara, Mario Recker
Publikováno v:
eLife, Vol 6 (2017)
The Zika virus has emerged as a global public health concern. Its rapid geographic expansion is attributed to the success of Aedes mosquito vectors, but local epidemiological drivers are still poorly understood. Feira de Santana played a pivotal role
Externí odkaz:
https://doaj.org/article/c926c9c80e254541a8606f8994a5b3c4
Autor:
Christian Julian Villabona-Arenas, Raquel Elvira Ocazionez Jimenez, Cinthy Lorena Jimenez Silva
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 6, p e0004653 (2016)
Externí odkaz:
https://doaj.org/article/92494bdc740f4f3ba3c55b529ede7c5a
Autor:
Christian Julian Villabona-Arenas, Adriano Mondini, Irene Bosch, Diane J Schimdt, Carlos E Calzavara-Silva, Paolo M de A Zanotto, Maurício L Nogueira
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63496 (2013)
Global dengue virus spread in tropical and sub-tropical regions has become a major international public health concern. It is evident that DENV genetic diversity plays a significant role in the immunopathology of the disease and that the identificati
Externí odkaz:
https://doaj.org/article/0e39a36422e3482ca21c0456726f1e60
Autor:
Christian Julian Villabona-Arenas, Adriano Mondini, Irene Bosch, Diane Schimitt, Carlos E. Calzavara-Silva, Paolo M. de A Zanotto, Maurício L. Nogueira
Publikováno v:
PLoS ONE, Vol 8, Iss 6 (2013)
Externí odkaz:
https://doaj.org/article/aba7aef0d0c74ce28ab6f076529782b2
Autor:
Ciara McCarthy, Nikos I. Bosse, Damien Tully, William Waites, Kaja Abbas, Christopher Jarvis, Sam Abbott, Stefan Flasche, Mark Jit, Billy Quilty, Rachael Pung, Graham Medley, David Hodgson, Yang Liu, Matthew Quaife, Simon Procter, Christian Julian Villabona Arenas
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-12 (2021)
Procter, S R, Abbas, K, Flasche, S, Griffiths, U, Hagedorn, B, O’Reilly, K M & Jit, M 2021, ' SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns : a modelling study ', BMC Medicine, vol. 19, no. 1, 198 . https://doi.org/10.1186/s12916-021-02072-8
medRxiv
article-version (status) pre
article-version (number) 2
BMC Medicine
Procter, S R, Abbas, K, Flasche, S, Griffiths, U, Hagedorn, B, O’Reilly, K M & Jit, M 2021, ' SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns : a modelling study ', BMC Medicine, vol. 19, no. 1, 198 . https://doi.org/10.1186/s12916-021-02072-8
medRxiv
article-version (status) pre
article-version (number) 2
BMC Medicine
BackgroundThe COVID-19 pandemic has disrupted the delivery of immunisation services globally. Many countries have postponed vaccination campaigns out of concern about infection risks to the staff delivering vaccination, the children being vaccinated,
Autor:
Tewodaj Mengistu, Timothy W Russell, Stefan Flasche, Thibaut Jombart, Simon R Procter, Emily Dansereau, Carl A. B. Pearson, Katherine E. Atkins, Christian Julian Villabona-Arenas, Daniel R Hogan, Emily Nightingale, Quentin J Leclerc, Gwenan M. Knight, Akira Endo, Hamish Gibbs, Petra Klepac, Andrew Clark, Arminder K Deol, W. John Edmunds, Adam J. Kucharski, Nicholas G Davies, Jon C Emery, Sebastian Funk, Rein M G J Houben, Mark Jit, Yang Liu, Kaja Abbas, Stéphane Hué, Charlie Diamond, Kevin van Zandvoort, Christopher I Jarvis, Amy Gimma, Nikos I Bosse, Sam Abbott, Kiesha Prem, Kathleen M. O’Reilly, Billy J Quilty, Graham F. Medley, Joel Hellewell, James D Munday, Alicia Rosello, Megan Auzenbergs, Samuel Clifford, Rosalind M Eggo, Fiona Yueqian Sun, Damien C. Tully
Publikováno v:
The Lancet Global Health
Abbas, K, Procter, S R, van Zandvoort, K, Clark, A, Funk, S, Mengistu, T, Hogan, D, Dansereau, E & Jit, M & Flasche, S 2020, ' Routine childhood immunisation during the COVID-19 pandemic in Africa : a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection ', The Lancet Global Health, vol. 8, no. 10, pp. e1264-e1272 . https://doi.org/10.1016/S2214-109X(20)30308-9
Abbas, K, Procter, S R, van Zandvoort, K, Clark, A, Funk, S, Mengistu, T, Hogan, D, Dansereau, E & Jit, M & Flasche, S 2020, ' Routine childhood immunisation during the COVID-19 pandemic in Africa : a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection ', The Lancet Global Health, vol. 8, no. 10, pp. e1264-e1272 . https://doi.org/10.1016/S2214-109X(20)30308-9
Background: National immunisation programmes globally are at risk of suspension due to the severe health system constraints and physical distancing measures in place to mitigate the ongoing COVID-19 pandemic. We aimed to compare the health benefits o
Autor:
Katherine E. Atkins, Christian Julian Villabona-Arenas, Olivier Gascuel, Stéphane Hué, Anna Zhukova, Luc Blassel
Publikováno v:
Current Opinion in Virology
Current Opinion in Virology, Elsevier, 2021, 51, pp.56-64. ⟨10.1016/j.coviro.2021.09.009⟩
Current Opinion in Virology, 2021, 51, pp.56-64. ⟨10.1016/j.coviro.2021.09.009⟩
Blassel, L, Zhukova, A, Villabona-Arenas, C J, Atkins, K E, Hué, S & Gascuel, O 2021, ' Drug resistance mutations in HIV : new bioinformatics approaches and challenges ', Current Opinion in Virology, vol. 51, pp. 56-64 . https://doi.org/10.1016/j.coviro.2021.09.009
Current Opinion in Virology, Elsevier, 2021, 51, pp.56-64. ⟨10.1016/j.coviro.2021.09.009⟩
Current Opinion in Virology, 2021, 51, pp.56-64. ⟨10.1016/j.coviro.2021.09.009⟩
Blassel, L, Zhukova, A, Villabona-Arenas, C J, Atkins, K E, Hué, S & Gascuel, O 2021, ' Drug resistance mutations in HIV : new bioinformatics approaches and challenges ', Current Opinion in Virology, vol. 51, pp. 56-64 . https://doi.org/10.1016/j.coviro.2021.09.009
International audience; Drug resistance mutations appear in HIV under treatment pressure. Resistant variants can be transmitted to treatmentnaive individuals, which can lead to rapid virological failure and can limit treatment options. Consequently,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::906fde77d52f1e1c1a45de5e9d8b9f5f
https://researchonline.lshtm.ac.uk/id/eprint/4664046/1/1-s2.0-S1879625721001073-main.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4664046/1/1-s2.0-S1879625721001073-main.pdf
Autor:
Alexander Mentzer, David Brealey, Paul Collini, Mahdad Noursadeghi, Charlotte Summers, Graciela Isabel García Dorival, Andrew Ustianowski, Damien Tully, Lorna Finch, Innocent Gerald Asiimwe, Stuart Hartshorn, Gary Leeming, Lance Turtle, Quentin Leclerc, Thushan De Silva, Lauren Lett, Chris Davis, Christopher Jarvis, Wei Shen Lim, Malcolm Gracie Semple, Tom Fletcher, Katie Ahmed, Manu Shankar-Hari, Wendy Barclay, Ruth Keogh, Chrysa Koukorava, Patrick Lillie, Ingeborg Welters, Suzannah Lant, Paul Klenerman, Stefan Flasche, Louise Sigfrid, Mark Jit, Anil Sharma, Billy Quilty, Rebecca Jensen, Effrossyni Gkrania-Klotsas, Robyn Kiy, Ahilanandan Dushianthan, Graham Medley, Christopher Green, Mark Peters, Paul Dark, Luke Hodgson, Emma Thomson, Kenneth A McLean, Yang Liu, Matthew Quaife, William Paxton, Ascanio Tridente, Shona Moore, Simon Procter, Dan Hawcutt, Christian Julian Villabona Arenas
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Health Services Research
Investigators, ISARICC & Dark, P 2021, ' Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. ', BMC Health Services Research, vol. 21, no. 1, 566 . https://doi.org/10.1186/s12913-021-06509-x
BMC HEALTH SERVICES RESEARCH
2021, ' Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England ', BMC Health Services Research, vol. 21, no. 1, pp. 566 . https://doi.org/10.1186/s12913-021-06509-x
BMC Health Services Research
Investigators, ISARICC & Dark, P 2021, ' Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. ', BMC Health Services Research, vol. 21, no. 1, 566 . https://doi.org/10.1186/s12913-021-06509-x
BMC HEALTH SERVICES RESEARCH
2021, ' Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England ', BMC Health Services Research, vol. 21, no. 1, pp. 566 . https://doi.org/10.1186/s12913-021-06509-x
Background Predicting bed occupancy for hospitalised patients with COVID-19 requires understanding of length of stay (LoS) in particular bed types. LoS can vary depending on the patient’s “bed pathway” - the sequence of transfers of individual